期刊文献+

格列美脲联合胰岛素治疗老年2型糖尿病的价值分析 被引量:2

Value analysis of glimepiride combined with insulin in the treatment of elderly patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨格列美脲联合胰岛素治疗老年2型糖尿病的价值。方法:收治老年2型糖尿病患者300例,分为两组。对照组给予胰岛素治疗,观察组在对照组基础上给予格列美脲治疗,比较两组疗效、不良反应发生率、血糖水平恢复正常时间。结果:观察组不良反应发生率2.00%、血糖水平恢复正常时间(15.58±2.56)d,优于对照组(P<0.05)。观察组总有效率94.67%,高于对照组(P<0.05)。结论:格列美脲联合胰岛素治疗老年2型糖尿病的疗效显著,不良反应较小。 Objective:To investigate the value of glimepiride combined with insulin in the treatment of elderly patients with type 2 diabetes mellitus.Methods:300 cases of elderly patients with type 2 diabetes mellitus were divided into two groups.The control group was treated with insulin,and the observation group was treated with glimepiride based on the control group.The curative effect,incidence of adverse reaction,the time of blood glucose levels returning to normal between groups were compared.Results:The incidence of adverse reaction in the observation group was 2.00%,and the time of blood glucose levels returning to normal was (15.58±2.56)d,which were better than those in the control group (P<0.05).The total effective rate of the observation group was 94.67% ,which was higher than that of the control group (P<0.05).Conclusion:Glimepiride combined with insulin in the treatment of elderly patients with type 2 diabetes mellitus had significant curative effect and less adverse reactions.
作者 冯慧玲 Feng Huiling(Shangdi Community Health Service Center of Haidian District in Beijing 100094)
出处 《中国社区医师》 2017年第4期25-25,27,共2页 Chinese Community Doctors
关键词 格列美脲 老年2型糖尿病 胰岛素 Glimepiride Type 2 diabetes mellitus Insulin
  • 相关文献

参考文献7

二级参考文献51

  • 1Gijs WD Landman,Henk JG Bilo,Sebastiaan T Houweling,Nanne Kleefstra.Chromium does not belong in the diabetes treatment arsenal: Current evidence and future perspectives[J].World Journal of Diabetes,2014,5(2):160-164. 被引量:3
  • 2宋晓燕,陈蔷,齐晓燕.六味地黄丸对早期糖尿病肾病患者红细胞醛糖还原酶活性的影响[J].中国中西医结合杂志,2004,24(12):1087-1090. 被引量:52
  • 3吴昆仑,吴眉.六味地黄丸(汤)药理研究及临床应用新进展[J].中成药,2005,27(11). 被引量:34
  • 4李向晖,宋扬,王立祥,雷联会.老年危重病患者应激性高血糖的强化胰岛素治疗[J].中国急救医学,2007,27(6):530-532. 被引量:17
  • 5中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志,2011,3(6):54-109.
  • 6Muscelli E, Casolaro A, Gasldelli A, et al.Mechamisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes [J ]. J Clin Endocrinal Metab, 2012, 97 (8) : 2818 -2826.
  • 7Aso Y, Ozeki N, Terasawa T, et al. Serum level of soluble CD26/dipeptidyl peptidase - 4 (DPP- 4 ) predicts the response to sitsglip- tin, a DPP -4 inhibitor, in patients with type 2 diabetes controlled inadequately by metform- in and/or sulfonylurea [ J ]. Transl Res, 2012, 159 (1): 25-31.
  • 8Fadini GP, Boscaro E, Albiero M, et al. The oral dipeptidyl peptidase -4 inhibitor sitaglip- tin increases circulating endothelial progenitor cell in patients with type 2 diabetes [J]. Dia- betes Care, 2010, 33 (7) : 1607 -1609.
  • 9Jelsing J, Vrang N, van Witteloostuijn SB, et al. The DPP -4 inhibitor linagliptin delays the on- set of diabetes and preserves i3 - cell mass in non- obese diabetic mice [ J]. J Endocrinol, 2012, 214 (3): 381-387.
  • 10Kirino Y , Sato Y, Kamimoto T, et al. Inter- relationship of dipeptidyl peptldase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozoto- ein - induced model using wild - type and DPP4- deficient rats [ J ]. J Endocrinol, 2009, 200 (1): 53-61.

共引文献302

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部